Asahi Kasei Pharma Corp:企業の戦略的SWOT分析

◆英語タイトル:Asahi Kasei Pharma Corp - Strategic SWOT Analysis Review
◆商品コード:GDPH135987SA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥28,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥42,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Asahi Kasei Pharma Corp – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Asahi Kasei Pharma Corp (Asahi Kasei Pharma), a subsidiary of Asahi Kasei Corp, manufactures and markets diagnostic reagents, prescription drugs, and enzymes for diagnostic reagents. Its prescription drugs are used for the treatment of osteoporosis pain, disseminated intravascular coagulation, bone loss, dysuria accompanying benign prostatic hyperplasia, nocturia, proteinuria in nephrotic syndrome and lupus nephritis, among others. Asahi Kasei Pharma offers assay kits for glycemic control and to detect prediabetes. The company’s pipeline products are intended for the treatment of chemotherapy-induced peripheral neuropathy, osteoporosis with high risk of fracture, Lupus nephritis and nephrotic syndrome and severe sepsis with coagulopathy, among others. It has facilities in Shizuoka, and Nagoya, Japan. Asahi Kasei Pharma is headquartered in Tokyo, Japan.

Asahi Kasei Pharma Corp Key Recent Developments

Nov 18,2020: Asahi Kasei Pharma contracts ProBioGen for the advancement of their biologics pipeline
Oct 13,2020: Asahi Kasei Pharma to solicit proposals for drug discovery research
Aug 05,2020: Asahi Kasei providing samples of hyaluronic acid nanogel as a new pharmaceutical excipient

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Asahi Kasei Pharma Corp – Key Facts
Asahi Kasei Pharma Corp – Key Employees
Asahi Kasei Pharma Corp – Major Products and Services
Asahi Kasei Pharma Corp – History
Asahi Kasei Pharma Corp – Company Statement
Asahi Kasei Pharma Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Asahi Kasei Pharma Corp – Business Description
Asahi Kasei Pharma Corp – SWOT Analysis
SWOT Analysis – Overview
Asahi Kasei Pharma Corp – Strengths
Asahi Kasei Pharma Corp – Weaknesses
Asahi Kasei Pharma Corp – Opportunities
Asahi Kasei Pharma Corp – Threats
Asahi Kasei Pharma Corp – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Asahi Kasei Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Asahi Kasei Pharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Asahi Kasei Pharma Corp, Recent Deals Summary
Section 4 – Company’s Recent Developments
Nov 18, 2020: Asahi Kasei Pharma contracts ProBioGen for the advancement of their biologics pipeline
Oct 13, 2020: Asahi Kasei Pharma to solicit proposals for drug discovery research
Aug 05, 2020: Asahi Kasei providing samples of hyaluronic acid nanogel as a new pharmaceutical excipient
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Asahi Kasei Pharma Corp, Key Facts
Asahi Kasei Pharma Corp, Key Employees
Asahi Kasei Pharma Corp, Major Products and Services
Asahi Kasei Pharma Corp, History
Asahi Kasei Pharma Corp, Other Locations
Asahi Kasei Pharma Corp, Subsidiaries
Asahi Kasei Pharma Corp, Key Competitors
Asahi Kasei Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Asahi Kasei Pharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Asahi Kasei Pharma Corp, Recent Deals Summary

★海外企業調査レポート[Asahi Kasei Pharma Corp:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • University of Alabama at Birmingham-製薬・医療分野:企業M&A・提携分析
    Summary University of Alabama at Birmingham (UAB), a subsidiary of University of Alabama System is an educational university that offers undergraduate and graduate programs. The university provides graduate programs in arts and sciences, health professions, medicine, nursing, business, dentistry, ed …
  • Sensile Medical AG:医療機器:M&Aディール及び事業提携情報
    Summary Sensile Medical AG (Sensile) is a medical device company that develops and produces key technologies for liquid drug delivery devices. The company develops products in the areas of micro insulin delivery and glucose monitoring systems. Its pipeline products comprise sensepatch and senseflex. …
  • Medicenna Therapeutics Corp (MDNA):製薬・医療:M&Aディール及び事業提携情報
    Summary Medicenna Therapeutics Corp (Medicenna), formerly A2 Acquisition Corp, is a clinical stage immuno-oncology company. The company develops empowered cytokines (EC) and superkines for the treatment of cancer. Its pipeline products include MDNA55, MDNA109, MDNA209, MDNA57, MDNA413, and MDNA132. …
  • Avantec Vascular Corp:製品パイプライン分析
    Summary Avantec Vascular Corp (Avantec Vascular), a subsidiary of Goodman Co Ltd is a medical device company that develops cardiovascular interventional and peripheral vascular devices. The company's products comprise balloon catheter, aspiration catheter, device delivery system, micro catheter, gui …
  • The Yomiuri Shimbun:企業の戦略的SWOT分析
    The Yomiuri Shimbun - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Trina Solar Co Ltd (688599):企業の財務・戦略的SWOT分析
    Trina Solar Co Ltd (688599) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • NS Solutions Corp (2327):企業の財務・戦略的SWOT分析
    NS Solutions Corp (2327) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Neoleukin Therapeutics Inc (NLTX):企業の財務・戦略的SWOT分析
    Summary Neoleukin Therapeutics Inc (Neoleukin), formely Aquinox Pharmaceuticals Inc is a biopharmaceutical company develops next generation immunotherapies to treat immunological disorders. The company's lead drug candidate NL-201 is a combined IL-2 and IL-15 protein therapeutic used as an agonist i …
  • CIRCOR Aerospace Products Group:企業の戦略・SWOT・財務情報
    CIRCOR Aerospace Products Group - Strategy, SWOT and Corporate Finance Report Summary CIRCOR Aerospace Products Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Chong Kun Dang Pharmaceutical Corp (185750):製薬・医療:M&Aディール及び事業提携情報
    Summary Chong Kun Dang Pharmaceutical Corp (CKD Pharma) manufactures, distributes, imports and exports prescription drugs, active pharmaceutical ingredients (APIs), over-the-counter (OTC) drugs, health supplements and consumer health products. Its product portfolio includes prescription products for …
  • Autoliv Inc (ALV):企業の財務・戦略的SWOT分析
    Autoliv Inc (ALV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Asahi Kasei Corp (3407)-医療機器分野:企業M&A・提携分析
    Summary Asahi Kasei Corp (Asahi Kasei), formerly Asahi Chemical Industry Co. Ltd., manufactures, processes, and sells chemical products. It is a holding company of Asahi Kasei Group. The product portfolio of the company includes polymers, acrylonitrile, styrene, diagnostic reagents, foam insulation …
  • Arup Group Ltd:企業の戦略的SWOT分析
    Arup Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Q BioMed Inc (QBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Q BioMed Inc (Q BioMed), formerly ISMO Tech Solutions Inc, is a biomedical acceleration and development company. The company offers Strontium Chloride SR89, a radiopharmaceutical agent for the treatment of pain associated with metastatic bone cancer. It develops Man-01, a pre-clinical lead c …
  • EMS SA:企業の戦略的SWOT分析
    EMS SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Qlik Technologies Inc:企業のM&A・事業提携・投資動向
    Qlik Technologies Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Qlik Technologies Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Takashimaya Company, Limited:企業の戦略・SWOT・財務分析
    Takashimaya Company, Limited - Strategy, SWOT and Corporate Finance Report Summary Takashimaya Company, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Sunshine Oilsands Ltd (2012):石油・ガス:M&Aディール及び事業提携情報
    Summary Sunshine Oilsands Ltd (Sunshine Oilsands) is an oil and gas company that develops holdings of oil sands and PN&G leases. The company owns and controls oil sands leases. Its properties include Thickwood, West Ells, Muskwa, Harper, Legend Lake and Portage, among others. Sunshine Oilsands also …
  • HPQ Silicon Resources Inc (HPQ):企業の財務・戦略的SWOT分析
    Summary HPQ Silicon Resources Inc (HPQ Silicon), formerly Uragold Bay Resources, is a mining and mineral exploration company. The company carries out the business of acquisition, exploration, production and development of silicon, gold and quartz properties, among others. It holds interests in The B …
  • Trina Solar Ltd:電力:M&Aディール及び事業提携情報
    Summary Trina Solar Ltd (Trina Solar) is a vertically-integrated solar power products manufacturer. The company manufactures a wide variety of PV modules, both monocrystalline and multicrystalline; ingots, wafers, cells and solar modules. The company also designs, constructs, sells and operates sola …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆